RE:RE:RE:I just don't think people fully grasp what has happened here Furthermore if you understood the mechanisms behind DEALs like the bought deals you referred to you would understand how they are not even close to being the same.
Here's how deals tend to work. I'm not picking on any specific one I've just done enough financings to be well aware of the game. Typically the bought deal goes to exisitng shareholders close to the company. The deal is announced at a discount, the exising holders that are "taking down the deal" sell shares they hold above the offering price and replace those shares with the offering capturing what ever profit they can between the offering price and what they get.
That process keeps going until there is the stock is trading at the offering price. By then the momentum is gone so the stock tends to drift even lower.
CB ofered a 30+% premium and are not "selling down" the deal. So there is no pressure on the stock. Once you understand how things work, you will understand how wrong you are.
Buckshot26 wrote: Wrong. A bought deal does not come with $40B worth of IP behind it. A bought deal is passive, this was a takeover that exisitng shareholder have been granted a way, through holding their shares of particapation.
Clarus writing Aphria a cheque at below the current share price is dilutive, hence the trading afterwards. Your examples are wrong.
EdiblesRlife wrote: You think the markets are rational? Also, the CB deal is essentially a bought deal at $48. Look at all other bought deals in the past 3 months in this sector. Most are trading below the BD price. For example, Aphria - $11.85, Canntrust - $9. Just to name two, and even after this insane past week those two still aren't at the bought deal financing. Meaning, you can still get in on those companies for under what "the big guys" buy in at.
Just cuz CB bought in at $48 doesn't mean that now the floor is $48. This is just a BD, shares in exchange for money.
The only difference is the size and the purchaser is a special interest purchaser not just a large institutional investor.
So, obviously not exactly comparable, but to say this is going much much higher based on the $48 BD price, doesn't mean too much
Buckshot26 wrote: Essentially half of canopy was just capitalized at $48+. This is as i said the other day a new company really being run by CB and capitalized at $48. The fact that we actually traded in the high 30's low 40's for two days in mind boggling to me. When do retail etc get a better price in than the big guys. When do "the big guys" come in with the IP of a $40B juggernaut?
Canopy is now the official Proxy trade of any positive developments for mj around the globe. This is the new ground floor. People waiting on some major correction are going to be extrememly dissapointed.
We're going higher, much much higher.